Disclaimer: These are personal views of the writer. They do not necessarily reflect the opinion of www-business-standard-com-nalsar.knimbus.com or the Business Standard newspaper
Clinical advances and digital technologies are at an extraordinary crossroads that is pushing the frontiers of preventive, predictive and precision medicine, using artificial intelligence (AI), bioengineering, digitisation of clinical trials and improved understanding of human pathogen control.
Just as the ECG sensor on your health app uses electrical sensors on the back of the wearable wristband to measure the health of your heart, EEG sensors embedded in earbuds can measure brain health and quantify brain activity, including cognitive decline over time.
In the early days of the Covid-19 pandemic, bioengineering and AI were extensively utilised to understand the behaviour of the SARS-Cov2 virus to harness the advances in gene- and genome-editing at scale to accelerate the development of diagnostic tests, medicines, and vaccines. Genetic medicine is already being used to detect the risk of ALS with high predictivity. ALS, short for
TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.
Subscribe To Insights
Key stories on business-standard.com are available to premium subscribers only.Already a BS Premium subscriber? Log in NOW
What you get on Business Standard Premium?
- Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
- Pick your 5 favourite companies, get a daily email with all news updates on them.
- Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
- Preferential invites to Business Standard events.
- Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.